BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28028025)

  • 1. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
    Drexler HG; Nagel S; Quentmeier H
    Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.
    Carratt SA; Kong GL; Curtiss BM; Schonrock Z; Maloney L; Maniaci BN; Blaylock HZ; Baris A; Druker BJ; Braun TP; Maxson JE
    Blood; 2022 Aug; 140(6):644-658. PubMed ID: 35482940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Apr; ():. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW
    J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.
    Tran A; Wong M
    Blood; 2021 Dec; 138(26):2890. PubMed ID: 34967865
    [No Abstract]   [Full Text] [Related]  

  • 10. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
    Gao J; Han S; Deng B; Deng Y; Gao X
    Ann Hematol; 2023 Nov; ():. PubMed ID: 37993585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
    Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
    Carreño-Tarragona G; Álvarez-Larrán A; Harrison C; Martínez-Ávila JC; Hernández-Boluda JC; Ferrer-Marín F; Radia DH; Mora E; Francis S; González-Martínez T; Goddard K; Pérez-Encinas M; Narayanan S; Raya JM; Singh V; Gutiérrez X; Toth P; Amat-Martínez P; Mcilwaine L; Alobaidi M; Mayani K; McGregor A; Stuckey R; Psaila B; Segura A; Alvares C; Davidson K; Osorio S; Cutting R; Sweeney CP; Rufián L; Moreno L; Cuenca I; Smith J; Morales ML; Gil-Manso R; Koutsavlis I; Wang L; Mead AJ; Rozman M; Martínez-López J; Ayala R; Cross NCP
    Blood Adv; 2023 May; 7(9):1672-1681. PubMed ID: 36375042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
    Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
    Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration.
    Harada N; Mukai D; Izuta Y; Shibano I; Kizawa Y; Shiragami H; Ohnishi N; Hosaka N; Mugitani A
    Pathol Int; 2024 Feb; 74(2):93-95. PubMed ID: 38050833
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
    Gao JP; Zhai LJ; Gao XH; Min FL
    J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
    Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY; Song IC; Kim J; Kwon GC
    Ann Diagn Pathol; 2024 Apr; 71():152317. PubMed ID: 38642470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review].
    Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Management of Chronic Neutrophilic Leukemia.
    Szuber N; Tefferi A
    Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.